Keyphrases
Metastatic Disease
100%
Castration-resistant Prostate Cancer
100%
Oligometastatic
100%
Prostate Cancer
83%
Oligometastatic Prostate Cancer
83%
Tumor Protein p53 (TP53)
66%
Radiation Therapy
50%
Metastatic Lesions
50%
Career Goals
50%
Androgen Deprivation Therapy
50%
Treatment Type
33%
Proposed Work
33%
Treatment Paradigms
33%
Improved Outcomes
33%
Oncologists
33%
Local Therapy
33%
Hormone Therapy
33%
Drug Therapy
16%
Clinical Trials
16%
Genetic mutation
16%
Immediate Effect
16%
Specific Genes
16%
Response Predictors
16%
Time to Tumor Progression
16%
Last Five Years
16%
Prostate Cancer Metastasis
16%
Gene TP53
16%
Oligometastatic Disease
16%
Drug Target
16%
Research Time
16%
Impact on Patients
16%
Medical School
16%
Quality of Life
16%
Therapeutic Avenues
16%
Tumor Genetics
16%
Rutgers University
16%
United States
16%
Response to Radiation
16%
New Therapeutics
16%
Mentorship
16%
Pharmacologic
16%
Systemic Therapy
16%
Prostate Cancer Progression
16%
Treatment Validation
16%
Chemotherapy
16%
Prostate Cancer Patients
16%
Physician-scientist
16%
Tumor
16%
Delay Time
16%
Johns Hopkins
16%
Treatment Decisions
16%
Disease Progression
16%
Junior Faculty
16%
Medical Training
16%
Predictive Information
16%
Medicine and Dentistry
Protein P53
100%
Prostate Cancer
100%
Metastatic Carcinoma
58%
Malignant Neoplasm
25%
Androgen Deprivation Therapy
25%
Radiation Therapy
25%
Hormone Therapy
16%
Neoplasm
16%
Local Therapy
16%
Side Effect
16%
Oncologist
16%
Diseases
16%
Gene Mutation
8%
Tumor Progression
8%
Drug Therapy
8%
Cancer Growth
8%
Drug Delivery System
8%
Clinical Trial
8%
Systemic Therapy
8%
Quality of Life
8%
Nursing and Health Professions
Protein P53
100%
Prostate Cancer
100%
Metastasis
58%
Malignant Neoplasm
25%
Androgen Deprivation Therapy
25%
Side Effect
16%
Oncologist
16%
Hormonal Therapy
16%
Neoplasm
16%
Local Therapy
16%
Radiotherapy
16%
Diseases
16%
Quality of Life
8%
Tumor Growth
8%
Systemic Therapy
8%
Cancer Growth
8%
Drug Therapy
8%
Drug Targeting
8%